The intricate crosstalk between GBM cells and these immune components begins with the tumor cells themselves, as genetic alteration in GBM cells, notably NF1 deficiency, can drive the recruitment and infiltration of microglia macrophages [86]. This evidence concerns the gene NF1 and glioblastoma.